HALF YEARLY RESULTS
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 04
3427.35
+203.70 (+ 6.32%)
Volume
12978
Prev. Close
3223.65
Open Price
3300.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 04
3420.00
+174.90 (+ 5.39%)
Volume
269490
Prev. Close
3245.10
Open Price
3259.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Halfyearly Results
for the last 5 years.
|
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
57936.86
|
P/BV
|
34.64
|
Book Value ( ₹ )
|
98.74
|
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3456/1921
|
FV/ML
|
10/1
|
P/E(X)
|
62.46
|
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.58
|
(₹ in Crs.)
| Net Sales/Income from operations | 1912.44 | 1811.05 | 1715.85 | 1691.40 | 1581.27 |
| Total Income From Operations | 1912.44 | 1811.05 | 1715.85 | 1691.40 | 1581.27 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 200.28 | 270.58 | 279.81 | 225.18 | 138.82 |
| Purchase of Traded Goods | 455.63 | 389.48 | 418.26 | 434.82 | 302.41 |
| Increase/Decrease in Stocks | 41.87 | 9.36 | -34.97 | -34.67 | 184.11 |
| Employees Cost | 277.71 | 301.99 | 314.18 | 310.21 | 301.83 |
| Depreciation | 33.52 | 33.27 | 35.21 | 34.47 | 33.59 |
| Other Expenses | 316.03 | 291.27 | 265.75 | 328.03 | 259.54 |
| Total Expenses | 1325.04 | 1295.95 | 1278.24 | 1298.04 | 1220.30 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 587.40 | 515.10 | 437.61 | 393.36 | 360.97 |
| Other Income | 74.52 | 68.04 | 58.21 | 65.27 | 51.57 |
| P/L Before Interest, Excpt. Items & Tax | 661.92 | 583.14 | 495.82 | 458.63 | 412.54 |
| Interest | 0.67 | 0.64 | 1.09 | 0.71 | 0.74 |
| P/L Before Exceptional Items & Tax | 661.25 | 582.50 | 494.73 | 457.92 | 411.80 |
| Exceptional Items | 0.00 | 4.69 | -160.91 | 17.30 | -0.97 |
| P/L Before Tax | 661.25 | 587.19 | 333.82 | 475.22 | 410.83 |
| Tax | 172.53 | 156.85 | 95.25 | 129.10 | 115.32 |
| P/L After Tax from Ordinary Activities | 488.72 | 430.34 | 238.57 | 346.12 | 295.51 |
| Net Profit/Loss For the Period | 488.72 | 430.34 | 238.57 | 346.12 | 295.51 |
| | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 28.85 | 25.40 | 14.08 | 20.43 | 17.44 |
| Diluted EPS (Rs.) | 28.85 | 25.40 | 14.08 | 20.43 | 17.44 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 28.85 | 25.40 | 14.08 | 20.43 | 17.44 |
| Diluted EPS (Rs.) | 0.00 | 25.40 | 0.00 | 20.43 | 0.00 |
| | | | | | |
| PBITOE Margin (%) | 30.71 | 28.44 | 25.50 | 23.25 | 22.82 |
| PBTE Margin (%) | 34.57 | 32.16 | 28.83 | 27.07 | 26.04 |
| PBT Margin (%) | 34.57 | 32.42 | 19.45 | 28.09 | 25.98 |
| PAT Margin (%) | 25.55 | 23.76 | 13.90 | 20.46 | 18.68 |